Lineage Cell Therapeutics (LCTX) Property, Plant & Equipment (Net) Growth (1y) (2011 - 2026)
Lineage Cell Therapeutics (LCTX) Property, Plant & Equipment (Net) Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PP&E (Net) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 24.71% |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 12.77% |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | -99.85% |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 1.70% |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -79.16% |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 10.87% |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 19.14% |
| 10 | Lineage Cell Therapeutics | 270.61 Mn | 212.77 Mn | 1.07 Mn | 11.62% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 11.62% |
| Mar 31, 2026 | 16.19% |
| Dec 31, 2025 | 13.99% |
| Sep 30, 2025 | 7.15% |
| Jun 30, 2025 | 11.74% |
| Mar 31, 2025 | 2.14% |
| Dec 31, 2024 | 0.27% |
| Sep 30, 2024 | -58.53% |
| Jun 30, 2024 | -62.00% |
| Mar 31, 2024 | -62.32% |
| Dec 31, 2023 | -60.43% |
| Sep 30, 2023 | 4.34% |
| Jun 30, 2023 | 37.24% |
| Mar 31, 2023 | 22.78% |
| Dec 31, 2022 | 16.44% |
| Sep 30, 2022 | -1.61% |
| Jun 30, 2022 | -22.74% |
| Mar 31, 2022 | -11.07% |
| Dec 31, 2021 | -13.46% |
| Sep 30, 2021 | -2.50% |